2-(2-(Methoxymethoxy)propanoyl)-N-(2-phenoxyethyl)hydrazinecarboxamide is an intermediate in the synthesis of Nefazodone (N389100), a selective serotonin 5-HT2 receptor antagonist. A novel antidepressant that shows no cardiac toxicity or anticholinergic activity common with tricyclic antidepressants.